UiPath (PATH) Price Target Cut Despite Strong ARR Growth

UiPath, Inc. (NYSE:PATH) ranks among the stocks that could 10x over the next 10 years. On March 16, BMO Capital reduced its price target for UiPath, Inc. (NYSE:PATH) to $14 from $17, retaining a Market Perform rating on the company’s shares. The company achieved a strong close to fiscal year 2026, exceeding high-end forecasts on key measures.

The company reported sustained stabilization in net new ARR, indicating improved execution and a healthier growth profile. In addition, UiPath, Inc. (NYSE:PATH) provided a fiscal 2027 ARR growth estimate of roughly 10.8%, projecting net new ARR of $200 million vs $187 million in the previous fiscal year.

BMO Capital increased its fiscal year 2027 ARR and revenue expectations slightly. The firm cited the $200 million AI-product ARR measure as encouraging. It also stated that investors will require further proof of ongoing AI monetization in order to stay loyal and support the company’s stock.

UiPath, Inc. (NYSE:PATH) is a software company focused on automation and orchestration, offering a platform that helps organizations deploy and manage automated workflows, including AI agent-led processes, across enterprise systems.

While we acknowledge the risk and potential of PATH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PATH and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.